Arrowhead Pharmaceuticals Receives FDA Breakthrough Therapy Designation for Plozasiran
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 62.75 +2.01 (3.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $60.74 | 52 Week High | $8.22 | |||
| Open | $60.72 | 52 Week Low | $3.07 | |||
| Day High | $62.99 | P/E | N/A | |||
| Day Low | $60.44 | EPS | $-1.30 | |||
| Volume | 2,764,849 | |||||
